866-997-4948 (US-Canada Toll Free)

Global Markets Direct is a leading provider of global business intelligence and market analysis. The company publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information. With a large dedicated research and analysis capability, Global Markets Direct employs...

Show More

Global Markets Direct is a leading provider of global business intelligence and market analysis. The company publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information. With a large dedicated research and analysis capability, Global Markets Direct employs rigorous primary and secondary research techniques in developing unique data sets and research materials.

At the heart of Global Markets Direct are unique databases, updated live, covering millions of rows of key information for the studied industry at a global level.

Show Less
  • Allergic Rhinitis - Pipeline Review, H1 2015

    Jan 2015

    By Global Markets Direct

    Pharmaceutical

    198 Pages

    Global Markets Directs, Allergic Rhinitis Pipeline Review, H1 2015, provides an overview of the Allergic Rhinitiss therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Allergic Rhinitis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration...

    USD 2000View Report
  • Metastatic Pancreatic Cancer - Pipeline Review, H1 2015

    Jan 2015

    By Global Markets Direct

    Oncology

    354 Pages

    Global Markets Directs, Metastatic Pancreatic Cancer Pipeline Review, H1 2015, provides an overview of the Metastatic Pancreatic Cancers therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Metastatic Pancreatic Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of...

    USD 2000View Report
  • Wet (Neovascular / Exudative) Macular Degeneration - Pipeline Review, H1 2015

    Jan 2015

    By Global Markets Direct

    Pharmaceutical

    226 Pages

    Global Markets Directs, Wet (Neovascular / Exudative) Macular Degeneration Pipeline Review, H1 2015, provides an overview of the Wet (Neovascular / Exudative) Macular Degenerations therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Wet (Neovascular / Exudative) Macular Degeneration, complete with comparative analysis at various...

    USD 2000View Report
  • Brain Cancer - Pipeline Review, H1 2015

    Jan 2015

    By Global Markets Direct

    Pharmaceutical

    263 Pages

    Global Markets Directs, Brain Cancer Pipeline Review, H1 2015, provides an overview of the Brain Cancers therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Brain Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and...

    USD 2000View Report
  • Dementia - Pipeline Review, H1 2015

    Jan 2015

    By Global Markets Direct

    Pharmaceutical

    166 Pages

    Global Markets Directs, Dementia Pipeline Review, H1 2015, provides an overview of the Dementias therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Dementia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type,...

    USD 2000View Report
  • Non-Alcoholic Steatohepatitis - Pipeline Review, H1 2015

    Jan 2015

    By Global Markets Direct

    Therapeutic Area

    215 Pages

    Global Markets Directs, Non-Alcoholic Steatohepatitis Pipeline Review, H1 2015, provides an overview of the Non-Alcoholic Steatohepatitiss therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Non-Alcoholic Steatohepatitis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of...

    USD 2000View Report
  • Diarrhea - Pipeline Review, H1 2015

    Jan 2015

    By Global Markets Direct

    Pharmaceutical

    171 Pages

    Global Markets Directs, Diarrhea Pipeline Review, H1 2015, provides an overview of the Diarrheas therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Diarrhea, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type,...

    USD 2000View Report
  • Candidiasis - Pipeline Review, H1 2015

    Jan 2015

    By Global Markets Direct

    Pharmaceutical

    135 Pages

    Global Markets Directs, Candidiasis Pipeline Review, H1 2015, provides an overview of the Candidiasiss therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Candidiasis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule...

    USD 2000View Report
  • Metastatic Renal Cell Carcinoma - Pipeline Review, H1 2015

    Jan 2015

    By Global Markets Direct

    Oncology

    213 Pages

    Global Markets Directs, Metastatic Renal Cell Carcinoma Pipeline Review, H1 2015, provides an overview of the Metastatic Renal Cell Carcinomas therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Metastatic Renal Cell Carcinoma, complete with comparative analysis at various stages, therapeutics assessment by drug target,...

    USD 2000View Report
  • Diabetic Macular Edema - Pipeline Review, H1 2015

    Jan 2015

    By Global Markets Direct

    Diabetes

    177 Pages

    Global Markets Directs, Diabetic Macular Edema Pipeline Review, H1 2015, provides an overview of the Diabetic Macular Edemas therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Diabetic Macular Edema, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of...

    USD 2000View Report
  • Hodgkin Lymphoma - Pipeline Review, H1 2015

    Jan 2015

    By Global Markets Direct

    Oncology

    244 Pages

    Global Markets Directs, Hodgkin Lymphoma Pipeline Review, H1 2015, provides an overview of the Hodgkin Lymphomas therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Hodgkin Lymphoma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration...

    USD 2000View Report
  • Endometriosis - Pipeline Review, H1 2015

    Jan 2015

    By Global Markets Direct

    Pharmaceutical

    127 Pages

    Global Markets Directs, Endometriosis Pipeline Review, H1 2015, provides an overview of the Endometriosiss therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Endometriosis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and...

    USD 2000View Report
  • Autism - Pipeline Review, H1 2015

    Jan 2015

    By Global Markets Direct

    Pharmaceutical

    154 Pages

    Global Markets Directs, Autism Pipeline Review, H1 2015, provides an overview of the Autisms therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Autism, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along...

    USD 2000View Report
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) - Pipeline Review, H1 2015

    Jan 2015

    By Global Markets Direct

    Pharmaceutical

    167 Pages

    Global Markets Directs, Coronary Artery Disease (CAD) (Ischemic Heart Disease) Pipeline Review, H1 2015, provides an overview of the Coronary Artery Disease (CAD) (Ischemic Heart Disease)s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Coronary Artery Disease (CAD) (Ischemic Heart Disease), complete with comparative analysis...

    USD 2000View Report
  • Pertussis - Pipeline Review, H1 2015

    Jan 2015

    By Global Markets Direct

    Pharmaceutical

    99 Pages

    Global Markets Directs, Pertussis Pipeline Review, H1 2015, provides an overview of the Pertussiss therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Pertussis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type,...

    USD 2000View Report
  • Chemotherapy Induced Neutropenia - Pipeline Review, H1 2015

    Jan 2015

    By Global Markets Direct

    Pharmaceutical

    109 Pages

    Global Markets Directs, Chemotherapy Induced Neutropenia Pipeline Review, H1 2015, provides an overview of the Chemotherapy Induced Neutropenias therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Chemotherapy Induced Neutropenia, complete with comparative analysis at various stages, therapeutics assessment by drug target,...

    USD 2000View Report
  • Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline Review, H1 2015

    Jan 2015

    By Global Markets Direct

    Pharmaceutical

    111 Pages

    Global Markets Directs, Acute Renal Failure (ARF) (Acute Kidney Injury) Pipeline Review, H1 2015, provides an overview of the Acute Renal Failure (ARF) (Acute Kidney Injury)s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Acute Renal Failure (ARF) (Acute Kidney Injury), complete with comparative analysis at various stages,...

    USD 2000View Report
  • Spinal Muscular Atrophy (SMA) - Pipeline Review, H1 2015

    Jan 2015

    By Global Markets Direct

    Pharmaceutical

    132 Pages

    Global Markets Directs, Spinal Muscular Atrophy (SMA) Pipeline Review, H1 2015, provides an overview of the Spinal Muscular Atrophy (SMA)s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Spinal Muscular Atrophy (SMA), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of...

    USD 2000View Report
  • Post-Traumatic Stress Disorder (PTSD) - Pipeline Review, H1 2015

    Jan 2015

    By Global Markets Direct

    Pharmaceutical

    115 Pages

    Global Markets Directs, Post-Traumatic Stress Disorder (PTSD) Pipeline Review, H1 2015, provides an overview of the Post-Traumatic Stress Disorder (PTSD)s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Post-Traumatic Stress Disorder (PTSD), complete with comparative analysis at various stages, therapeutics assessment by drug...

    USD 2000View Report
  • Atrial Fibrillation - Pipeline Review, H1 2015

    Jan 2015

    By Global Markets Direct

    Cardiovascular Devices

    103 Pages

    Global Markets Directs, Atrial Fibrillation Pipeline Review, H1 2015, provides an overview of the Atrial Fibrillations therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Atrial Fibrillation, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of...

    USD 2000View Report
  • Amyloidosis - Pipeline Review, H1 2015

    Jan 2015

    By Global Markets Direct

    Pharmaceutical

    133 Pages

    Global Markets Directs, Amyloidosis Pipeline Review, H1 2015, provides an overview of the Amyloidosiss therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Amyloidosis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule...

    USD 2000View Report
  • Cognitive Impairment Associated With Schizophrenia (CIAS) - Pipeline Review, H1 2015

    Jan 2015

    By Global Markets Direct

    Pharmaceutical

    96 Pages

    Global Markets Direct’s, ‘Cognitive Impairment Associated With Schizophrenia (CIAS) Pipeline Review, H1 2015’, provides an overview of the Cognitive Impairment Associated With Schizophrenia (CIAS)’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Cognitive Impairment Associated With Schizophrenia...

    USD 2000View Report
  • Growth Hormone Deficiency - Pipeline Review, H1 2015

    Jan 2015

    By Global Markets Direct

    Pharmaceutical

    110 Pages

    Global Markets Directs, Growth Hormone Deficiency Pipeline Review, H1 2015, provides an overview of the Growth Hormone Deficiencys therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Growth Hormone Deficiency, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA),...

    USD 2000View Report
  • Diabetic Neuropathic Pain - Pipeline Review, H1 2015

    Jan 2015

    By Global Markets Direct

    Diabetes

    106 Pages

    Global Markets Directs, Diabetic Neuropathic Pain Pipeline Review, H1 2015, provides an overview of the Diabetic Neuropathic Pains therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Diabetic Neuropathic Pain, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA),...

    USD 2000View Report
  • High Triglyceridemia - Pipeline Review, H1 2015

    Jan 2015

    By Global Markets Direct

    Cardiovascular Devices

    105 Pages

    Global Markets Directs, High Triglyceridemia Pipeline Review, H1 2015, provides an overview of the High Triglyceridemias therapeutic pipeline. This report provides comprehensive information on the therapeutic development for High Triglyceridemia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of...

    USD 2000View Report